Guttate Psoriasis clinical trials at UCSF

1 research study open to eligible people

Guttate psoriasis is a skin condition with small, red spots. At UCSF, we're studying how a medicine called guselkumab helps people with this condition. We're looking at how their bodies respond to the treatment.

Showing trials for

  • Guselkumab Immunogenetics

    open to eligible people ages 18 years and up

    This is a two-arm open-label study to evaluate the clinical and immunogenetic responses of patients with plaque or guttate psoriasis to treatment with guselkumab.

    San Francisco, California

Last updated: